374 related articles for article (PubMed ID: 15583748)
1. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
Kuliopulos A; Mohanlal R; Covic L
Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748
[TBL] [Abstract][Full Text] [Related]
2. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F
Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
[TBL] [Abstract][Full Text] [Related]
4. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
Saklatvala J; Rawlinson L; Waller RJ; Sarsfield S; Lee JC; Morton LF; Barnes MJ; Farndale RW
J Biol Chem; 1996 Mar; 271(12):6586-9. PubMed ID: 8636072
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A(2) promotes soluble CD40 ligand release from human platelets.
Enomoto Y; Adachi S; Matsushima-Nishiwaki R; Doi T; Niwa M; Akamatsu S; Tokuda H; Ogura S; Yoshimura S; Iwama T; Kozawa O
Atherosclerosis; 2010 Apr; 209(2):415-21. PubMed ID: 19932480
[TBL] [Abstract][Full Text] [Related]
7. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase.
Iida Y; Doi T; Tokuda H; Matsushima-Nishiwaki R; Tsujimoto M; Kuroyanagi G; Yamamoto N; Enomoto Y; Tanabe K; Otsuka T; Iwama T; Ogura S; Kozawa O; Iida H
Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():73-81. PubMed ID: 25500336
[TBL] [Abstract][Full Text] [Related]
9. Functional role of p38 mitogen activated protein kinase in platelet activation induced by a thromboxane A2 analogue and by 8-iso-prostaglandin F2alpha.
Minuz P; Gaino S; Zuliani V; Tommasoli RM; Benati D; Ortolani R; Zancanaro C; Berton G; Santonastaso CL
Thromb Haemost; 2002 May; 87(5):888-98. PubMed ID: 12038794
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
11. P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation.
Huang Z; Liu P; Zhu L; Li N; Hu H
Thromb Haemost; 2014 Jul; 112(1):142-50. PubMed ID: 24633352
[TBL] [Abstract][Full Text] [Related]
12. Amyloid beta peptide-activated signal pathways in human platelets.
Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY
Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035
[TBL] [Abstract][Full Text] [Related]
13. The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets.
Dangelmaier C; Jin J; Daniel JL; Smith JB; Kunapuli SP
Eur J Biochem; 2000 Apr; 267(8):2283-9. PubMed ID: 10759852
[TBL] [Abstract][Full Text] [Related]
14. The effects of an inhibitor of diglyceride lipase on collagen-induced platelet activation.
Jackson EC; Ortar G; McNicol A
J Pharmacol Exp Ther; 2013 Dec; 347(3):582-8. PubMed ID: 24042163
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Wang TM; Chan CP; Lin BR; Yeung SY; Yeh CY; Cheng RH; Jeng JH
PLoS One; 2014; 9(8):e104310. PubMed ID: 25122505
[TBL] [Abstract][Full Text] [Related]
16. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
17. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3.
Li Z; Zhang G; Feil R; Han J; Du X
Blood; 2006 Feb; 107(3):965-72. PubMed ID: 16210341
[TBL] [Abstract][Full Text] [Related]
18. Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid.
Poeckel D; Tausch L; Altmann A; Feisst C; Klinkhardt U; Graff J; Harder S; Werz O
Br J Pharmacol; 2005 Oct; 146(4):514-24. PubMed ID: 16086030
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Wang TM; Yeung SY; Jeng PY; Liao CH; Lin TY; Lin CC; Lin BR; Jeng JH
Atherosclerosis; 2011 Dec; 219(2):559-65. PubMed ID: 21993412
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Chang MC; Chang HH; Chan CP; Chou HY; Chang BE; Yeung SY; Wang TM; Jeng JH
Toxicol Appl Pharmacol; 2012 Sep; 263(3):287-95. PubMed ID: 22789837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
